Skip to content

Drug interactions

Disopyramide + Sorafenib

Severity: Major

Disopyramide and Sorafenib: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Disopyramide is a class Ia antiarrhythmic with a well-known risk of QT prolongation and torsades de pointes. Sorafenib adds its own QT-prolonging effect, increasing arrhythmic risk.

What this interaction means in plain words

Disopyramide and Sorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Disopyramide belongs to Cardiovascular; Sorafenib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic prolongation of cardiac repolarization.

What to do

Avoid the combination if an alternative antiarrhythmic is available. If it is unavoidable, correct electrolytes and monitor the ECG closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Disopyramide and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Disopyramide with Sorafenib?

MediHelp rates the interaction as major. Disopyramide and Sorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Disopyramide is a class Ia antiarrhythmic with a well-known risk of QT prolongation and torsades de pointes. Sorafenib adds its own QT-prolonging effect, increasing arrhythmic risk.

How serious is the interaction between Disopyramide and Sorafenib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if an alternative antiarrhythmic is available. If it is unavoidable, correct electrolytes and monitor the ECG closely.

What other medicines interact with Sorafenib?

MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in